VOYA Investment Management
CASC

VOYA Investment Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History

VOYA Investment Management’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-7,504
Closed -$57K – 2609
2016
Q1 		$57K Hold
7,504
– – ﹤0.01% 2470
2015
Q4 		$100K Hold
7,504
– – ﹤0.01% 2483
2015
Q3 		$123K Sell
7,504
-2,670
-26% -$54.7K ﹤0.01% 2443
2015
Q2 		$228K Hold
10,174
– – ﹤0.01% 2422
2015
Q1 		$100K Hold
10,174
– – ﹤0.01% 2529
2014
Q4 		$116K Hold
10,174
– – ﹤0.01% 2565
2014
Q3 		$117K Hold
10,174
– – ﹤0.01% 2585
2014
Q2 		$198K Buy
+10,174
New +$179K ﹤0.01% 2567

Other funds holding CASC

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

VOYA Investment Management's CASC Position: Q2 2016 in Review

VOYA Investment Management sold out of Cascadian Therapeutics, Inc. (CASC) in Q2 2016, closing a stake of 7,504 shares — an estimated $57K sold.

VOYA Investment Management first reported a position in CASC in Q2 2014 and held it in 8 quarters. The position peaked at $228K in Q2 2015. 75 funds tracked by Wall St. Rank hold CASC as of Q2 2016.

  • VOYA Investment Management reported no remaining Cascadian Therapeutics, Inc. position as of Q2 2016 after selling out during the quarter.
  • VOYA Investment Management sold 7,504 Cascadian Therapeutics, Inc. shares in Q2 2016, an estimated $57K.
  • VOYA Investment Management first reported a position in Cascadian Therapeutics, Inc. in Q2 2014 and held it in 8 quarters.
  • VOYA Investment Management's Cascadian Therapeutics, Inc. position peaked at $228K in Q2 2015.
  • 75 funds tracked by Wall St. Rank held Cascadian Therapeutics, Inc. as of Q2 2016.

Based on VOYA Investment Management's 13F filing for Q2 2016, filed 15 Aug 2016.